Oct 4 (Reuters) - Promore Pharma AB PROMO.ST :
* PROMORE PHARMA PROMORE PHARMA CARRIES OUT A RIGHTS ISSUE
OF
APPROXIMATELY SEK 75 MILLION, UNDERWRITTEN UP TO 80 PERCENT, AND
INTENDS TO PUBLISH ITS INTERIM REPORT EARLY
* PURPOSE OF RIGHTS ISSUE IS TO ENSURE CONTINUED SUCCESSFUL
DEVELOPMENT OF PROMORE PHARMA'S TWO DRUG CANDIDATES
* NET PROCEEDS (INCLUDING COSTS RELATED TO UNDERWRITING
COMMITMENTS) IS EXPECTED TO AMOUNT TO APPROXIMATELY SEK 63
MILLION
* SUBSCRIPTION PRICE IS SEK 3.71
* IF RIGHTS ISSUE IS FULLY SUBSCRIBED, A TOTAL OF 20,235,090
SHARES WILL BE ISSUED
* SUBSCRIPTION PERIOD NOVEMBER 13 - 28, 2019
Source text for Eikon: ID:nWkr2WnBg5
Further company coverage: PROMO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587720920;))